Aberdeen Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2M | Sell |
406,694
-39,503
| -9% | -$1.58M | 0.03% | 474 |
|
|
2025
Q1 | $13.5M | Buy |
446,197
+44,696
| +11% | +$1.35M | 0.03% | 492 |
|
|
2024
Q4 | $14M | Buy |
401,501
+98,227
| +32% | +$3.43M | 0.03% | 446 |
|
|
2024
Q3 | $12.1M | Buy |
303,274
+56,357
| +23% | +$2.24M | 0.02% | 485 |
|
|
2024
Q2 | $11.8M | Buy |
246,917
+27,496
| +13% | +$1.31M | 0.02% | 482 |
|
|
2024
Q1 | $9.51M | Buy |
219,421
+83,002
| +61% | +$3.6M | 0.02% | 558 |
|
|
2023
Q4 | $6.9M | Buy |
+136,419
| New | +$6.9M | 0.02% | 619 |
|
|
2021
Q2 | – | Sell |
-5,197
| Closed | -$234K | – | 1026 |
|
|
2021
Q1 | $234K | Buy |
5,197
+405
| +8% | +$18.2K | ﹤0.01% | 971 |
|
|
2020
Q4 | $271K | Buy |
4,792
+543
| +13% | +$30.7K | ﹤0.01% | 931 |
|
|
2020
Q3 | $202K | Sell |
4,249
-3,620
| -46% | -$172K | ﹤0.01% | 922 |
|
|
2020
Q2 | $464K | Buy |
7,869
+18
| +0.2% | +$1.06K | ﹤0.01% | 866 |
|
|
2020
Q1 | $372K | Buy |
7,851
+213
| +3% | +$10.1K | ﹤0.01% | 865 |
|
|
2019
Q4 | $461K | Buy |
7,638
+132
| +2% | +$7.97K | ﹤0.01% | 887 |
|
|
2019
Q3 | $450K | Sell |
7,506
-20,294
| -73% | -$1.22M | ﹤0.01% | 865 |
|
|
2019
Q2 | $1.79M | Buy |
+27,800
| New | +$1.79M | ﹤0.01% | 758 |
|